Cost Effectiveness Analysis of Azacitidine in Patients with Acute Myeloid Leukemia With >30% Blasts and who are Not Candidate for Curative-Intend Chemotherapy
作者
PJ Villeneuve,Doug Coyle
出处
期刊:Value in Health [Elsevier BV] 日期:2018-05-01卷期号:21: S33-S33